Correlation Between Inozyme Pharma and Century Therapeutics
Can any of the company-specific risk be diversified away by investing in both Inozyme Pharma and Century Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Inozyme Pharma and Century Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Inozyme Pharma and Century Therapeutics, you can compare the effects of market volatilities on Inozyme Pharma and Century Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Inozyme Pharma with a short position of Century Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Inozyme Pharma and Century Therapeutics.
Diversification Opportunities for Inozyme Pharma and Century Therapeutics
0.51 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Inozyme and Century is 0.51. Overlapping area represents the amount of risk that can be diversified away by holding Inozyme Pharma and Century Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Century Therapeutics and Inozyme Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Inozyme Pharma are associated (or correlated) with Century Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Century Therapeutics has no effect on the direction of Inozyme Pharma i.e., Inozyme Pharma and Century Therapeutics go up and down completely randomly.
Pair Corralation between Inozyme Pharma and Century Therapeutics
Given the investment horizon of 90 days Inozyme Pharma is expected to under-perform the Century Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Inozyme Pharma is 1.31 times less risky than Century Therapeutics. The stock trades about -0.1 of its potential returns per unit of risk. The Century Therapeutics is currently generating about 0.02 of returns per unit of risk over similar time horizon. If you would invest 126.00 in Century Therapeutics on September 15, 2024 and sell it today you would lose (1.00) from holding Century Therapeutics or give up 0.79% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Inozyme Pharma vs. Century Therapeutics
Performance |
| Timeline |
| Inozyme Pharma |
| Century Therapeutics |
Inozyme Pharma and Century Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Inozyme Pharma and Century Therapeutics
The main advantage of trading using opposite Inozyme Pharma and Century Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Inozyme Pharma position performs unexpectedly, Century Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Century Therapeutics will offset losses from the drop in Century Therapeutics' long position.| Inozyme Pharma vs. Puma Biotechnology | Inozyme Pharma vs. Iovance Biotherapeutics | Inozyme Pharma vs. Day One Biopharmaceuticals | Inozyme Pharma vs. Zentalis Pharmaceuticals Llc |
| Century Therapeutics vs. Puma Biotechnology | Century Therapeutics vs. Iovance Biotherapeutics | Century Therapeutics vs. Day One Biopharmaceuticals | Century Therapeutics vs. Inozyme Pharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.
Other Complementary Tools
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins |